←Back to list

Devoted Health

Tech-enabled Medicare Advantage insurer with in-house clinical care.
Devoted Health is a tech-enabled Medicare Advantage insurer founded by Athenahealth co-founders Todd and Ed Park, combining a health plan with an in-house clinical group (Devoted Medical). Sacra-tracked revenue reached $3.27B in 2024, up 69% YoY.
Healthcare 📍 Waltham, MA Founded 2017
Current Valuation
$13B
as of 2023-Q4
DECACORN

QL Price

$22B
-13% vs last round
QuantLogix's current estimate for Devoted Health, published 2026-10-08 — below the last disclosed round of $25B (2026-09).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round $25B 2026-09 weight 0.93
Secondary market print $16B 2026-06-27 weight 0.54
How this price has held up
No round has priced for Devoted Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-10-08 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Devoted Health →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Devoted Health, 2026-10-08 (d3dac3de1b34fe37). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookrumored

Is Devoted Health going public in 2027?
An IPO is rumored for 2027, with nothing filed. Devoted Health remains private and the date is not the company's.
What is Devoted Health's valuation in 2026?
Devoted Health is valued at $13B as of 2023-Q4, set by its Series F-Prime ($317M, Jan 2026). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Devoted Health filed an S-1?
No public S-1 is on file for Devoted Health as of 10/08/2026; the IPO is rumored.
Who are Devoted Health's investors?
Devoted Health's investors include Andreessen Horowitz, GIC, Premji Invest, Uprising, Maverick Ventures, Frist Cressey Ventures and 1 more.
How much has Devoted Health raised?
Devoted Health has raised $3.0B in total, most recently a Series F-Prime of $317M in Jan 2026.
Is Devoted Health publicly traded — can you buy Devoted Health stock?
No. Devoted Health is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Devoted Health on its Pre-IPO Access Desk.
How to actually get exposure to Devoted Health →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

CEO
Todd Park
Founded
2017
HQ
Waltham, MA
Employees
2000+
Total Raised
$3.0B
Est. Revenue
$3.3B (2024)
Growth
Serving over 466,000 members across 29 states as of January 2026, up 121% year over year, funded by $366M of fresh equity in two tranches (a $48M Series F in November 2025 and a $317M Series F-Prime in January 2026)
Last Round
Series F-Prime — $317M (Jan 2026)
IPO Status
rumored

Fundraising Status

Series F-Prime · $317M · 9 mo ago
rumoredTotal raised $3.0B

Secondary Market

Implied price / share
$35.51
Last round price / share
$56.25
vs last round
-36.9%
Open interest
1
Last round price vs secondary price
Last round vs current secondary price per share$56.25Last round$35.51Current
Secondary price return by period
Secondary market period returns3-month+11.2%6-month+11.1%1-year+11.1%All-time-35.4%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series F-Prime$317MJan 2026——

Talent Signal

Hiring trend
▲ Hiring uptrend
+17% vs 2026-08
Open roles
83
via workday
Product-build share
30%
engineering, research, product, design
Trajectory
expanding
balanced build + GTM — 30% builders vs 70% go-to-market/G&A — scaling both sides.
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by month71Aug '2683Sep '26
Open roles by function
Open roles by functionOther45Clinical & Science22Ops & People6Finance & Strategy5Engineering2Legal & Policy1Product1Sales & GTM1
■ product-building   ■ go-to-market / G&A
Urgent Care & Telehealth Physician - Care OnDemandPharmacy Fraud Program ManagerTransitions of Care Manager, Clinical GuidePharmacy Benefits Senior ManagerCardiovascular Clinical GuideClinical Guide Part A: (UM) Utilization Management Nurse
Counted from Devoted Health's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.

Founders & Key People

Ed ParkTodd Park

Investors

Andreessen Horowitz · GIC · Premji Invest · Uprising · Maverick Ventures · Frist Cressey Ventures · ICONIQ Capital

Products

  • Devoted Health Medicare Advantage plans
  • Devoted Medical (in-house clinical group)
  • Member-facing digital health platform

Competitors

Humana · UnitedHealth (Optum) · Clover Health · Alignment Healthcare · Bright Health
HealthTechInsuranceMedicare AdvantageTelehealth
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2023-Q4. Refreshed quarterly.